Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.7 EUR
-1.26%
Updated:
May 9, 2024
Vita 34 AG
Income from Continuing Operations
|
Vita 34 AG
Income from Continuing Operations Peer Comparison
Comparables:
F
FME
F
FRE
E
1846
SYAB
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Income from Continuing Operations
-€25.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Income from Continuing Operations
€732.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-2%
|
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Income from Continuing Operations
€238m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-18%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Income from Continuing Operations
HK$133.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Income from Continuing Operations
€93m
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Income from Continuing Operations?
Income from Continuing Operations
-25.2m
EUR
-25.2m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Income from Continuing Operations amounts to -25.2m EUR.
What is Vita 34 AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-63%
-63%
Over the last year, the Income from Continuing Operations growth was -63%.
You don't have any saved screeners yet
